🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
3.380
-0.050 (-1.46%)
At close: Nov 19, 2026, 4:00 PM EST
3.330
-0.050 (-1.48%)
After-hours: Nov 19, 2026, 7:30 PM EST

eXoZymes Earnings Call Transcripts

Fiscal Year 2026

  • Tyferyn advanced toward commercialization with Curia selected for manufacturing and technology transfer underway. Q3 operating costs rose, while the reported net loss benefited from a non-cash warrant-liability gain; launch timing remains dependent on scale-up, regulatory steps, and a marketing partner.

  • NCT manufacturing achieved a 10x productivity breakthrough, improving economics and commercial readiness. Cash position strengthened to $5.65M after $6.59M in new financing, supporting operations through 2026. Strategic focus on high-value nutraceuticals and pharmaceuticals, with NCT market launch targeted for H1 2027.

Fiscal Year 2025

Fiscal Year 2024